Navigation Links
amfAR announces inaugural Mathilde Krim Fellowship Awards for AIDS research
Date:1/4/2008

New York City, January 4, 2008 amfAR, the Foundation for AIDS Research, has announced that it will award more than $1 million in the inaugural round of Mathilde Krim Fellowships in Basic Biomedical Research.

Named in honor of amfARs founding chairman, Dr. Mathilde Krim, the Krim Fellowship program is a new research initiative created to support bright young scientists seeking innovative prevention and treatment solutions to HIV/AIDS. Since the early days of the epidemic, Dr. Krim has been a leading advocate of increased support for research on a disease that others have often preferred to ignore.

amfAR was overwhelmed by the extraordinarily high caliber of proposals submitted, said Dr. Rowena Johnston, amfARs vice president of research. This response underscores the urgent need for support of young researchers who bring fresh ideas and vigor to the field and who represent the future of HIV/AIDS research.

amfAR initiated the new program in response to the dwindling sources of support that are available to young scientists. Yet these same young researchers are often those with the most innovative and daring ideas ideas that have breakthrough potential.

With Mathilde Krim Fellowship support, these future leaders of AIDS research will be searching for new drug treatment candidates, looking to optimize vaccine design, and even investigating barriers to a cure for HIV infection.

amfAR has a long and proud history of supporting innovative research, said amfAR CEO Kevin Robert Frost. Our new Krim Fellowship program continues that tradition and takes it to a higher level. It is also a fitting tribute to the vision and unwavering commitment to research of our founding chairman.

Since it was founded in 1985, amfAR has supported the early studies behind almost every significant breakthrough in the treatment of HIV/AIDS, including studies that were critical to the development of protease inhibito
'/>"/>

Contact: Donald Kaplan
donald.kaplan@amfar.org
212-806-1602
amfAR, The Foundation for AIDS Research
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. amfARs MSM Initiative Seeks Proposals From Front-Line Groups Working on HIV in Developing Countries
2. amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...FRANKLIN, Mass., Sept. 5 /PRNewswire/ -- Arthrosur...eveloper of less-invasive joint,resurfacing system...e U.S.,FDA to begin its pivotal investigation for ...DA stated that "there are no outstanding safety,co...iation., Arthrosurface has been evaluating the sa...
(Date:9/5/2008)...The National Institute of Diabetes and Digestive a...nstitutes of Health (NIH), announces awards to eig...ive studies of urologic chronic pelvic pain disord...rostate. The total research investment for the fiv...ion. , "The launch of this novel research effort...
(Date:9/5/2008)...MIDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Saturd...e featured on the Oxygen Network show Today,s,Fami...is highlighted as a,leading medical device company...ith effective nebulizers and compressors that deli...ur vision is to improve the lives of those affecte...
(Date:9/5/2008)...ATLANTA, Sept. 5 /PRNewswire/ -- EthicAd, a nonpro...h through consumer education, announces,the launch... public better,understand direct-to-consumer (DTC)..., "Be Smart About Prescription Drug Advertising," ...and Research and was,developed by the FDA in partn...
Breaking Medicine News(10 mins):Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2
... Charan, a 72-year-old Rajasthan man who has pledg...exam, will have to wait longer for a wife. He has ...n as Sheojiram, the resident of Kohari village of ... here, has been taking the test for the last 37 ye...
...nt research has revealed that the COX enzymes inte...ll as function in the development of blood vessels...e University of Pennsylvania School of Medicine an...d reported in the online edition of Nature Medicin...
...iages (read heterosexual) are made in heaven, they...they made for each other? Homosexuality has been o... seems like the battle lines are only getting stro...hips. The U.S. president, during a recent radio a...
...deficit faced by the NHS in the last financial yea... expected. Many prominent health advisors //feel t...be a serious financial problem was seemingly only ...nisations and that the books would be balanced dur...
Other Medicine News:Health News:New Role of COX Enzymes Discovered 2Health News:Differently Wired and Gay – Are They Children of a Lesser God 2Health News:UK Government Plans On Tackling Health Service Deficits 2
(Date:9/4/2008)...- 100 mg cohort demonstrates potent antiviral acti... profile -, CAMBRIDGE, Mass., Sept. 4 /PRNew...Nasdaq: IDIX ), a biopharmaceutical company engag...he treatment of human viral,and other infectious d...,proof-of-concept study evaluating IDX899, a non-n...
(Date:9/3/2008)..., NAA says: Wrong Question Asked. Wrong Children ...ept. 3 /PRNewswire-USNewswire/ -- A Centers for Di...today claims there is no link,between the MMR vacc...AA),says this study does nothing to dispel the gro...on and raises several questions concerning design,...
(Date:9/3/2008)... September is National Vascular Disease ...RNewswire/ -- Diffusion Pharmaceuticals,LLC, a cli...ng new drugs,for the treatment of unmet medical ne...atients in a Phase I/II clinical trial of its lead...e trial, designated NCT00725881,on the clinicaltri...
(Date:9/3/2008)... Company to Discuss Phase 3 Plans ...- Agile Therapeutics, Inc.,announced today that i...n,the development of the company,s new, innovative... the company refers to by its internal product,cod...y successfully met its,primary endpoint of ovulati...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Tongue Drive system lets persons with disabilities operate powered wheelchairs computers 22909 1Tongue Drive system lets persons with disabilities operate powered wheelchairs computers 22909 2Tongue Drive system lets persons with disabilities operate powered wheelchairs computers 22909 3Tongue Drive system lets persons with disabilities operate powered wheelchairs computers 22909 4A single mechanism for hypertension insulin resistance and immune suppression 3813 1A single mechanism for hypertension insulin resistance and immune suppression 3813 2A single mechanism for hypertension insulin resistance and immune suppression 3813 3A single mechanism for hypertension insulin resistance and immune suppression 3813 4Heavy birthweight babies twice as likely to develop rheumatoid arthritis 22904 1Activity Linked Heat Illness Needs Prompt Attention 22901 1Activity Linked Heat Illness Needs Prompt Attention 22901 2Activity Linked Heat Illness Needs Prompt Attention 22901 3
...3, 2007--A part of the brain first,affected by Alz...www.nia.nih.gov/Alzheimers/">http://www.nia.nih.go...ne for the disorder, a brain,imaging study by rese... (NIMH), one of the National Institutes of Health ...tructure in the lower middle,part of the brains ou...
...USINESS WIRE)--Apr 25, 2007 - DuoCort AB,today ann...mg and,20 mg dual release hydrocortisone tablets f...9th European Congress of Endocrinology on,April 30...harmacokinetics of the new hydrocortisone tablets ...hat both the DuoCort 5 mg and 20 mg,hydrocortisone...
Other Medicine Technology:Cortex Area Thinner in Youth with Alzheimers-Related Gene 2Cortex Area Thinner in Youth with Alzheimers-Related Gene 3Cortex Area Thinner in Youth with Alzheimers-Related Gene 4DuoCort AB: DuoCort announces Phase I Data Presentation at the,European Congress of Endocrinology 2
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: